4
Changes in Ownership
Prelude Therapeutics Inc Filed Acc 0001562180-22-008192
Chief Financial Officer bought 10,000 shares at $4.76 ($47,600)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Chardonnet Laurent Chief Financial Officer | 2022-12-08 | Purchase | +10,000 | $4.76 | $47,600 | 35,873 | D |
| Open-market purchases · 10,000 sh · avg $4.76 · $47,600 | |||||||
Loading xslF345X03/primarydocument.xml…